Suppr超能文献

精神病的生物标志物:我们做到了吗?对1478种生物标志物的综合评价

Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.

作者信息

Fuentes-Claramonte Paola, Estradé Andrés, Solanes Aleix, Ramella-Cravaro Valentina, Garcia-Leon Maria Angeles, de Diego-Adeliño Javier, Molins Conrad, Fung Eric, Valentí Marc, Anmella Gerard, Pomarol-Clotet Edith, Oliver Dominic, Vieta Eduard, Radua Joaquim, Fusar-Poli Paolo

机构信息

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.

Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain.

出版信息

Schizophr Bull Open. 2024 Aug 30;5(1):sgae018. doi: 10.1093/schizbullopen/sgae018. eCollection 2024 Jan.

Abstract

BACKGROUND AND HYPOTHESIS

This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders.

STUDY DESIGN

We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool.

STUDY RESULTS

The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal -acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors.

CONCLUSIONS

While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.

摘要

背景与假设

本系统综述旨在全面综合外周、电生理、神经影像学、神经病理学及其他生物标志物与精神障碍诊断之间关联的证据。

研究设计

我们选取了截至2018年2月1日发表的关于精神障碍诊断生物标志物的观察性研究的系统综述和荟萃分析。数据提取按照系统综述和荟萃分析的首选报告项目(PRISMA)指南进行。使用标准化分类,将生物标志物与精神障碍之间关联的证据分类为令人信服、高度提示、提示、微弱或无显著性。质量分析使用多项系统综述评估(AMSTAR)工具。

研究结果

该系统综述纳入了110项荟萃分析或系统综述,对应3892项个体研究、1478种生物标志物和392210名参与者。没有因素显示出令人信服的证据水平。观察到转谷氨酰胺酶自身抗体水平(优势比[OR]=7.32;95%置信区间:3.36,15.94)、听觉事件相关电位中的失匹配负波(标准化均数差[SMD]=0.73;95%置信区间:0.5,0.96)、P300成分潜伏期(SMD=-0.6;95%置信区间:-0.83,-0.38)、脑室-脑比率(SMD=0.61;95%置信区间:0.5,0.71)和轻微身体异常(SMD=0.99;95%置信区间:0.64,1.34)具有高度提示性证据。观察到叶酸、丙二醛、脑源性神经营养因子、同型半胱氨酸、P50感觉门控(P50 S2/S1比率)、额叶N-乙酰天门冬氨酸和高频心率变异性具有提示性证据。在其余生物标志物中,626种发现了微弱证据,833种因素无显著性关联。

结论

虽然有几种生物标志物呈现出与精神障碍关联的高度提示性或提示性证据,但方法学偏倚和研究效能不足需要未来开展更高质量的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e3d/11369642/cbe1521f8b7e/sgae018_fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验